New Chicago-area plant for Germany's Vetter promises 300 jobs

Vetter to build production facility in Chicago area.

Vetter, a German company that specializes in contract aseptic filling, said it will build a production facility in the Chicago suburb of Des Plaines, IL. 

It’s expected that the facility will create about 300 jobs, and the company plans to eventually build up to 1 million square feet of space on the 17-acre site that used to be home to the Salvation Army’s central territory headquarters.

Details of the agreement between the Ravensburg, Germany-based CDMO and the state’s Department of Commerce and Economic Opportunity didn’t outline specific incentives given to Vetter as part of the deal, the Chicago Tribune reported.


Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

Still, the state said Vetter, which already has a production operation and offices in Skokie, plans to invest $320 million in the facility. 

Vetter, which is privately held, specializes in filling syringes and vials with liquid medicines in sterile environments. One of the company's customers is AbbVie ($ABBV), the seller of arthritis fighter Humira, the world's best-selling prescription drug. In addition to AbbVie, other big pharma companies based in Chicago’s northern suburbs include Abbott ($ABT) and Baxter ($BAX).

- here’s the release
- check out the Tribune story

Related Article:
Vetter putting $100M into its production network


Suggested Articles

Higher operating costs were behind a 17% slide in pretax profits last year at Allergan’s Mayo, Ireland, facility that produces Botox.

After a global scare over Zantac contamination, generic metformin could be next in line as regulators test for possible carcinogen contamination.

PCI Pharma Services debuts expansion of its plant in Rockford, Illinois.